Adorbs Inc financial data

Symbol
ADOB on OTC
Location
36 Fourth Ave. N, Saskatchewan, Saskatchewan, Canada
State of incorporation
Nevada
Fiscal year end
December 31
Former names
Soul Biotechnology Corp (to 10/27/2023)

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 9.86 % -8.53%
Quick Ratio 5.79 % +31%
Debt-to-equity 205 %
Return On Equity -539 % -523%
Return On Assets -176 % -227%
Operating Margin -572 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 599M shares
Common Stock, Shares, Outstanding 599M shares +698%
Entity Public Float 0 USD
Common Stock, Value, Issued 599K USD +698%
Weighted Average Number of Shares Outstanding, Basic 599M shares +698%
Weighted Average Number of Shares Outstanding, Diluted 599M shares +698%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 270K USD -61.4%
Cost of Revenue 66.3K USD +12.8%
General and Administrative Expense 276K USD +370%
Operating Income (Loss) -1.54M USD -425%
Nonoperating Income (Expense) -7.07K USD -1474%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.55M USD -425%
Net Income (Loss) Attributable to Parent -1.55M USD -404%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 36.3K USD +183%
Accounts Receivable, after Allowance for Credit Loss, Current 3.1K USD -13.9%
Inventory, Net 38.5K USD -21.6%
Assets, Current 53.4K USD -53.6%
Goodwill 512K USD -7.75%
Assets 884K USD +22.8%
Liabilities, Current 298K USD -73.2%
Liabilities 328K USD -71.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -87.1K USD -135%
Retained Earnings (Accumulated Deficit) -2.04M USD -320%
Stockholders' Equity Attributable to Parent 556K USD
Liabilities and Equity 884K USD +22.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32K USD +11.7%
Net Cash Provided by (Used in) Financing Activities 249 USD -99.4%
Net Cash Provided by (Used in) Investing Activities 20K USD
Common Stock, Shares Authorized 700M shares 0%
Common Stock, Shares, Issued 599M shares +698%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -31.6K USD -218%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.6K USD -82.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.6M USD -258%
Additional Paid in Capital 2.08M USD +7981%
Amortization of Intangible Assets 856K USD +3663%